MoneyWorks4Me

OneSource Specialty Pharma informs about press release

04 May 2026 Evaluate
OneSource Specialty Pharma has informed that it enclosed Press Release issued by the Company titled: OneSource Supports Second Generic Semaglutide Approval in Canada Enables commercialisation for the first two entrants in the world’s second-largest semaglutide market.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..